About the position
The Senior Director will lead the global launch of INZ-701, an ENPP1 Fc fusion protein enzyme replacement therapy designed to restore pyrophosphate and adenosine levels. This role demands a strategic thinker with a proven track record of successfully bringing rare disease pharmaceutical products to the market, coupled with the ability to navigate the complexities of global regulatory & reimbursement environments. This is a new role within an evolved organization operating model. The individual will be a key member of the Enzyme Therapies Marketing team, reporting to the Head of Marketing, Enzyme Therapies BU. This role will be accountable for creating the integrated commercial strategy for INZ-701, leading the global commercialization and launch efforts with the intent of maximizing market opportunities. S/he must have the proven ability to collaborate, influence across stakeholder groups, effectively network across the organization and communicate with senior leaders all within a fast moving, challenging and dynamic environment.
Responsibilities
- Develop and implement a comprehensive global launch strategy for INZ-701, ensuring alignment with business objectives and regulatory requirements.
- Lead a high-performing launch Brand team, fostering a culture of innovation, collaboration, and excellence.
- Identify and capitalize on market opportunities to optimize the reach and adoption of INZ-701, leveraging market research and competitive analysis.
- Lead the collaboration between the Enzyme Therapies BU Marketing and in-country Marketing ensuring strategic alignment that can support and address market launch opportunities and challenges.
- Deliver & ensure consistent branding, positioning, and messaging platforms across markets.
- Effectively partner with Supply Chain to ensure launch supply planning and readiness.
- Collaborate with key cross-functional partners such as Medical Affairs, Value, Access and Strategic Pricing, Worldwide R&D and Pipeline & Portfolio Strategy to develop a cohesive, insights-driven launch brand strategy and meeting the needs of BioMarin's strategic markets, balancing both near-term and long-term priorities.
- Engage with key stakeholders, including healthcare professionals, patient advocacy groups, and industry bodies, to drive awareness and support for INZ-701.
- Manage the budget for the launch program, ensuring efficient allocation of resources and monitoring financial performance against targets.
- Develop brand specific investor relations messaging.
- Leverage knowledge of the current and future market to provide insights for forecasting, strategic and corporate planning.
- Active contributor and member of Enzyme Therapies BU marketing team.
Requirements
- Degree in life sciences, business administration, or a related field.
- Minimum of 10 years of experience in the pharmaceutical or biotechnology industry.
- Demonstrated success in leading global product launches and navigating complex market landscapes.
- Strong strategic, analytical, and leadership skills with the ability to influence and inspire cross-functional teams.
- Excellent verbal and written communication skills, with the ability to effectively convey complex information to diverse audiences.
- Experience working in a global environment, with an understanding of diverse cultural and market dynamics.
Nice-to-haves
- Prior experience with enzyme replacement therapies or other biologics.
- Strong network within the pharmaceutical and biotechnology industry.
Benefits
- Company-sponsored medical, dental, vision, and life insurance plans.
- Discretionary annual bonus.
- Discretionary stock-based long-term incentives.
- Paid time off.
